About this data
Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.
GLP-1 RAs
- Company
- Shanghai 10th People's Hospital
- Mechanism
- Mechanism not yet reported
- Route
- Route not yet reported
- Recruiting trials
- 10 recruiting
Efficacy results: Not yet reported
10 recruiting studies currently listed on ClinicalTrials.gov.
Data source: ClinicalTrials.gov · trial data as of Sep 11, 2026
Find a Clinical Trial Near Me
See recruiting studies for GLP-1 RAs and check eligibility with the study team.
Trial details
-
Recruiting NCT NCT07006142
Effect of Prolonged Fasting Time on Gastric Residual Volume in Patients Taking GLP1 Receptor Agonists
Not yet reported Mayo Clinic 150 participants Est. completion 2026-08-30 1 siteOther conditions: Upper Endoscopy, GLP1-R-related DiseaseView official trial listing → -
Recruiting NCT NCT07012642
Efficacy of GLP-1 Receptor Agonists in Treating Upper and Lower Extremity Lymphedema
Not yet reported Advanced Reconstructive Surgery Alliance 110 participants Est. completion 2027-04-09 2 sites Stand-aloneOther conditions: LymphedemaView official trial listing → -
Recruiting NCT NCT07224880
Ellacor® Micro-Coring Technology® in Fitzpatrick Skin Types I-VI, Including Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists
Cytrellis Biosystems, Inc. 10 participants Est. completion 2026-02-28 1 siteOther conditions: glp1 Agonist, Gene Expression, Skin LaxityView official trial listing → -
Recruiting NCT NCT07225816
Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)
Not yet reported Novo Nordisk A/S 71 participants Est. completion 2027-01-06 1 siteOther conditions: ObesityView official trial listing → -
Recruiting NCT NCT07314684
GLP1-RAs Effects on Inflammatory and Endothelial Biomarkers in T2DM
Not yet reported Federico II University 80 participants Est. completion 2027-03-08 2 sitesType 2 diabetesView official trial listing → -
Recruiting NCT NCT07393360
Effect of a Food for Special Medical Purposes on Muscle Mass Preservation During GLP-1 RAs Weight Loss Treatment
Not yet reported Pharmanutra S.p.a. 144 participants Est. completion 2026-12 3 sitesOther conditions: Obesity & OverweightView official trial listing → -
Recruiting NCT NCT07437911
A Randomized, Triple-blind, Placebo-controlled Study to Evaluate the Effects of a Supplement on Nutrient Gaps and Gut Health Among Individuals Utilizing GLP-1 RAs
Not yet reported Athletic Greens International 120 participants Est. completion 2026-08 1 siteOther conditions: Nutrition Intake, Nutrition Status, Gastrointestinal Microbiome, GLP-1View official trial listing → -
Recruiting NCT NCT07605572
Impact of GLP-1 Receptor Agonists on Dry Eye Disease in Patients With Type 2 Diabetes Mellitus and Obesity
Attikon Hospital 100 participants Est. completion 2027-02-28 1 siteOther conditions: Dry Eye Disease (DED), Diabete Mellitus, GLP-1, Ocular Surface, Diabetes Type 2, CorneaView official trial listing → -
Recruiting NCT NCT07652333
The Effects of Strength Training on Muscle Mass and Mental Health in Adults Taking Obesity Medication
Not yet reported University of Pittsburgh 40 participants Est. completion 2027-05-31 1 site Stand-aloneOther conditions: Muscle Composition, Obesity, Quality of Life (QOL)View official trial listing → -
Recruiting NCT NCT07720414
Effects of GLP-1 RAs on Human Lactation Outcomes
University of Colorado, Denver 18 participants Est. completion 2028-06 1 siteOther conditions: Lactation, Weight LossView official trial listing → -
Completed NCT NCT02787551
Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period
Not yet reported Sanofi 514 participants Est. completion 2018-11-17 124 sites Added to GLP-1Type 2 diabetesView official trial listing → -
Status unknown NCT NCT03671733
Effects of GLP-1 RAs on Weight and Metabolic Indicators in Obese Patients
Not yet reported Xiangya Hospital of Central South University 150 participants Est. completion 2022-09-01 1 siteOther conditions: ObesityView official trial listing → -
Withdrawn NCT NCT04287179
SUSTAIN SWITCH: A Research Study to Compare Two Dose Schedules of Semaglutide Taken Once Weekly in People With Type 2 Diabetes
Not yet reported Novo Nordisk A/S Est. completion 2021-01-25 25 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT04866667
Observational Study of ASCVD Risks of Type 2 Diabetes in East China
Zhejiang Provincial People's Hospital 316 participants Est. completion 2024-05-31 1 siteType 2 diabetesCardiovascular disease Other conditions: LiraglutideView official trial listing → -
Completed NCT NCT04876027
GLP-1 RAs in Patients With Polycystic Ovary Syndrome (PCOS)
Not yet reported Shanghai 10th People's Hospital 68 participants Est. completion 2022-05-10 1 site Stand-aloneOther conditions: Polycystic Ovary SyndromeView official trial listing → -
Enrolling by invitation NCT NCT05872022
A Study to Evaluate Safety of Exposure to Wegovy During Pregnancy
Novo Nordisk A/S 728 participants Est. completion 2032-12-30 3 sitesOther conditions: Pregnancy, Obesity, OverweightView official trial listing → -
Completed NCT NCT05946148
Novel Antidiabetic Medications and Their Effect on Liver Steatosis (NAMELS-18)
National and Kapodistrian University of Athens 78 participants Est. completion 2021-05-31 1 siteOther conditions: Non-Alcoholic Fatty Liver Disease, Liver SteatosisView official trial listing → -
Completed NCT NCT06236672
Impact of GLP-1 RAs Compared to Basal Insulin Start in Patients Living With Type 2 Diabetes and Chronic Kidney Disease
LMC Diabetes & Endocrinology Ltd. 348 participants Est. completion 2023-11-29 1 siteType 2 diabetesChronic kidney diseaseView official trial listing → -
Completed NCT NCT06355219
Macrovascular and Microvascular Morbidity and Mortality After Metabolic Surgery Versus Medicines
Ali Aminian 3932 participants Est. completion 2024-05-20Type 2 diabetesHeart failure Other conditions: Obesity, Microvascular Disease, Macrovascular Disease, Major Adverse Cardiovascular Events, Nephropathy, Retinopathy, All Cause MortalityView official trial listing → -
Enrolling by invitation NCT NCT06581120
GLP_1 RA Ultrasound Study
Children's Hospital Medical Center, Cincinnati 100 participants Est. completion 2026-07 1 siteOther conditions: Glucagon Like Peptide-1 (GLP-1, Delayed Gastric Emptying, Risk of Aspiration, Diabetes, Morbid ObesityView official trial listing → -
Not yet recruiting NCT NCT06775093
Effects of GLP-1RAs on Reproductive Outcomes in PCOS and Obesity
Not yet reported Peking University Third Hospital 392 participants Est. completion 2027-12-31 1 site Stand-aloneOther conditions: Polycystic Ovary Syndrome, Obesity, Infertility, FemaleView official trial listing → -
Completed NCT NCT06913881
Comparative Cardiovascular Effectiveness of GLP-1 RAs vs. Insulin in Early-Onset Type 2 Diabetes
Karolinska Institutet 92100 participants Est. completion 2025-01-31 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT06981936
This Randomized Trial Aims to Investigate the Efficacy of Balanced Nutritional Tablets-Comprehensive Multivitamin and Mineral Supplements- in Preventing Micronutrient Deficiencies Among Patients Utilizing GLP-1 RAs for Weight Loss in Comparison to a Placebo Control
Not yet reported General Committee of Teaching Hospitals and Institutes, Egypt 150 participants Est. completion 2026-05-29 1 siteOther conditions: Micronutrient DeficienciesView official trial listing → -
Active, not recruiting NCT NCT07325435
Beta Cell Function in Type 2 Diabetes: Differential Effects of SGLT2 Inhibitors and GLIP-Receptor Agonists
Not yet reported MaryAnn Banerji 60 participants Est. completion 2028-06-30 1 siteType 2 diabetesView official trial listing → -
Not yet recruiting NCT NCT07391267
Pathogenesis of Chronic Kidney Disease Associated With Metabolic Dysfunction- Associated Fatty Liver Disease (MAFLD) and Treatment Response of Oral Semaglutide.
Not yet reported Institute of Liver and Biliary Sciences, India 90 participants Est. completion 2028-12-31 1 siteChronic kidney disease Other conditions: MAFLDView official trial listing → -
Not yet recruiting NCT NCT07687667
Effects of GLP-1RAs on Fertility Outcomes in Obese Women With PCOS
Not yet reported Peking University Third Hospital 406 participants Est. completion 2029-12 1 site Stand-aloneOther conditions: Polycystic Ovary Syndrome (PCOS), Obesity, Infertility, FemaleView official trial listing →
Efficacy history
Not yet reported.
Safety
Not yet reported.
Sources
Related On The Pen coverage
No related coverage yet.
This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.